[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-30983":3,"doc-seo-30983":21},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":4,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"update_tm":20},30983,7971461741311,"Ophelia","https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?_k=1778038333162525182",7,"Healthcare","Alcohol Use Disorder Pharmacotherapy Explanation","Follow-up management for a 46-year-old woman with alcohol use disorder focuses on relapse prevention after recent abstinence. Having stopped drinking for 2 weeks without withdrawal symptoms, she still experiences occasional cravings and fears relapse. The material emphasizes offering pharmacotherapy alongside psychosocial interventions for moderate to severe AUD by targeting alcohol’s reinforcing effects through opioid and glutamate modulation. It identifies acamprosate as a first-line relapse-reduction option, outlines its renal-focused clearance and renal dose adjustment, and contrasts alternatives such as benzodiazepines, disulfiram, and opioid antagonists.","cbCaimQ5azZdifuv","https://ap.wps.com/l/cbCaimQ5azZdifuv","pdf",12529297,1,1778364379,{"code":4,"msg":22,"data":23},"ok",{"site_id":24,"language":25,"slug":26,"title":13,"keywords":27,"description":14,"schema_data":28,"social_meta":62,"head_meta":64,"extra_data":66,"updated_unix":20},105,"en","alcohol-use-disorder-pharmacotherapy-explanation","",{"@graph":29,"@context":61},[30,47],{"@type":31,"itemListElement":32},"BreadcrumbList",[33,37,41,44],{"item":34,"name":35,"@type":36,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":38,"name":39,"@type":36,"position":40},"https://docshare.wps.com/document/","Document",2,{"item":42,"name":12,"@type":36,"position":43},"https://docshare.wps.com/document/healthcare/",3,{"item":45,"name":13,"@type":36,"position":46},"https://docshare.wps.com/document/alcohol-use-disorder-pharmacotherapy-explanation/30983",4,{"url":45,"name":13,"@type":48,"author":49,"headline":13,"publisher":51,"fileFormat":54,"description":14,"dateModified":55,"datePublished":55,"encodingFormat":54,"isAccessibleForFree":56,"interactionStatistic":57},"DigitalDocument",{"name":9,"@type":50},"Person",{"url":34,"name":52,"@type":53},"DocShare","Organization","application/pdf","2026-05-09",true,{"@type":58,"interactionType":59,"userInteractionCount":4},"InteractionCounter",{"@type":60},"ViewAction","https://schema.org",{"og:url":45,"og:type":63,"og:title":13,"og:site_name":52,"og:description":14},"article",{"robots":65,"canonical":45},"index,follow",{"doc_id":7,"site_id":24}]